Results 101 to 110 of about 35,805,673 (334)

EMT‐associated bias in the Parsortix® system observed with pancreatic cancer cell lines

Molecular Oncology, EarlyView.
The Parsortix® system was tested for CTC enrichment using pancreatic cancer cell lines with different EMT phenotypes. Spike‐in experiments showed lower recovery of mesenchymal‐like cells. This was confirmed with an EMT‐inducible breast cancer cell line.
Nele Vandenbussche, Renske Imschoot, Béatrice Lintermans, Lode Denolf, Joachim Taminau, Charlotte Fieuws, Geert Berx, Kris Gevaert, Kathleen B. M. Claes   +8 more
wiley   +1 more source

Consumers’ acceptance and willingness to pay for enriched foods: Evidence from a choice experiment in Italy

Future Foods
Over the last decades, consumer has evolved becoming increasingly responsible, showing a preference for those foods having a positive impact on health, society and environment.
Concetta Nazzaro, Marcello Stanco, Anna Uliano, Giuseppe Marotta   +3 more
doaj  

Enhanced Process Monitoring for the Maxwell Process via the CUSUM Control Chart and Its Application to the Carbon Fiber Industry

IEEE Access
Control charts are the diagnostic tools used in statistical applications for detecting possible changes in a process. One of the effective approaches for identifying smaller shifts in the process under the memory control charts is the cumulative sum ...
Zahid Khan, Faisal Shah, Attila I. Katona, Zsolt T. Kosztyan   +3 more
doaj   +1 more source

Investigating information systems with mixed-methods research [PDF]

, 2011
Mixed-methods research, which comprises both quantitative and qualitative components, is widely perceived as a means to resolve the inherent limitations of traditional single method designs and is thus expected to yield richer and more holistic findings.
Annansingh, F., Nunes, J.M.B., Peng, G.C.   +2 more
core  

A METHOD FOR THE QUANTITATIVE DETERMINATION OF TRYPSIN AND PEPSIN [PDF]

, 1923
John H. Northrop, Raymond G. Hussey
openalex   +1 more source

Tumor clusters with divergent inflammation and human retroelement expression determine the clinical outcome of patients with serous ovarian cancer

Molecular Oncology, EarlyView.
Analysis of treatment‐naïve high‐grade serous ovarian carcinoma (HGSOC) and control tissues for ERVs, LINE‐1 (L1), inflammation, and immune checkpoints identified five clusters with diverse patient recurrence‐free survivals. An inflammation score was calculated and correlated with retroelement expression, where one novel cluster (Triple‐I) with high ...
Laura Glossner, Markus Eckstein, Christoph Mark, Matthias W. Beckmann, Arndt Hartmann, Pamela L. Strissel, Reiner Strick   +6 more
wiley   +1 more source

A RAPID METHOD FOR THE QUANTITATIVE DETERMINATION OF ACETANILIDE IN HEADACHE POWDERS. [PDF]

, 1907
Atherton Seidell
openalex   +1 more source

A DIA‐MS‐based proteomics approach to find potential serum prognostic biomarkers in glioblastoma patients

Molecular Oncology, EarlyView.
A DIA‐MS‐based proteomics analysis of serum samples from GB patients and healthy controls showed that high levels of IL1R2 and low levels of CRTAC1 and HRG in serum are associated with poor survival outcomes for GB patients. These circulating proteins could serve as biomarkers for the prediction of outcome in patients with GB.
Anne Clavreul, François Guillonneau, Odile Blanchet, Hamza Lasla, Audrey Rousseau, Catherine Guette, Alice Boissard, Cécile Henry, Morgan Dhondt, Pascal Jézéquel, Philippe Menei, Jean‐Michel Lemée   +11 more
wiley   +1 more source

NOTE ON A METHOD OF QUANTITATIVELY ESTIMATING THE PHAGOCYTIC POWER OF THE LEUCOCYTES OF THE BLOOD [PDF]

, 1902
W. B. Leishman
openalex   +1 more source

Cytomegalovirus infection is common in prostate cancer and antiviral therapies inhibit progression in disease models

Molecular Oncology, EarlyView.
Human cytomegalovirus infection is common in normal prostate epithelium, prostate tumor tissue, and prostate cancer cell lines. CMV promotes cell survival, proliferation, and androgen receptor signaling. Anti‐CMV pharmaceutical compounds in clinical use inhibited cell expansion in prostate cancer models in vitro and in vivo, motivating investigation ...
Johanna Classon, Moa Stenudd, Margherita Zamboni, Kanar Alkass, Carl‐Johan Eriksson, Lars Pedersen, Alrik Schörling, Anna Thoss, Anders Bergh, Pernilla Wikström, Hans‐Olov Adami, Henrik Toft Sørensen, Henrik Druid, Jonas Frisén   +13 more
wiley   +1 more source